First Header Logo Second Header Logo

Connection

Vijay Gorantla to Transplantation Tolerance

This is a "connection" page, showing publications Vijay Gorantla has written about Transplantation Tolerance.
Connection Strength

1.248
  1. Gorantla VS, Schneeberger S, Brandacher G, Sucher R, Zhang D, Lee WP, Zheng XX. T regulatory cells and transplantation tolerance. Transplant Rev (Orlando). 2010 Jul; 24(3):147-59.
    View in: PubMed
    Score: 0.376
  2. Fisher JD, Balmert SC, Zhang W, Schweizer R, Schnider JT, Komatsu C, Dong L, Erbas VE, Unadkat JV, Aral AM, Acharya AP, Kulahci Y, Turnquist HR, Thomson AW, Solari MG, Gorantla VS, Little SR. Treg-inducing microparticles promote donor-specific tolerance in experimental vascularized composite allotransplantation. Proc Natl Acad Sci U S A. 2019 12 17; 116(51):25784-25789.
    View in: PubMed
    Score: 0.182
  3. Plock JA, Schnider JT, Schweizer R, Zhang W, Tsuji W, Waldner M, Solari MG, Marra KG, Rubin JP, Gorantla VS. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation. Transplantation. 2017 Jan; 101(1):e1-e11.
    View in: PubMed
    Score: 0.148
  4. Plock JA, Schnider JT, Zhang W, Schweizer R, Tsuji W, Kostereva N, Fanzio PM, Ravuri S, Solari MG, Cheng HY, Rubin PJ, Marra KG, Gorantla VS. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation. Transplantation. 2015 Sep; 99(9):1765-73.
    View in: PubMed
    Score: 0.135
  5. Jindal R, Unadkat J, Zhang W, Zhang D, Ng TW, Wang Y, Jiang J, Lakkis F, Rubin P, Lee WP, Gorantla VS, Zheng XX. Spontaneous resolution of acute rejection and tolerance induction with IL-2 fusion protein in vascularized composite allotransplantation. Am J Transplant. 2015 May; 15(5):1231-40.
    View in: PubMed
    Score: 0.130
  6. Lin CH, Zhang W, Ng TW, Zhang D, Jiang J, Pulikkottil B, Lakkis F, Gorantla VS, Lee WP, Brandacher G, Zheng XX. Vascularized osteomyocutaneous allografts are permissive to tolerance by induction-based immunomodulatory therapy. Am J Transplant. 2013 Aug; 13(8):2161-8.
    View in: PubMed
    Score: 0.116
  7. Gorantla VS, Brandacher G, Schneeberger S, Zheng XX, Donnenberg AD, Losee JE, Lee WP. Favoring the risk-benefit balance for upper extremity transplantation--the Pittsburgh Protocol. Hand Clin. 2011 Nov; 27(4):511-20, ix-x.
    View in: PubMed
    Score: 0.104
  8. Gorantla VS, Prabhune KA, Perez-Abadia G, Ildstad ST, Maldonado C, Orhun HI, Majzoub RK, Francois CG, Kakoulidis TP, Brouha PC, Anderson GL, Pidwell DJ, Breidenbach WC, Barker JH. Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease. Transplantation. 2003 Apr 15; 75(7):922-32.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.